Taipei Exchange - Delayed Quote TWD

TaiRx, Inc. (6580.TWO)

Compare
26.00
+0.50
+(1.96%)
At close: 2:59:24 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
5,082.00
5,082.00
6,923.00
5,141.00
3,359.00
Cost of Revenue
2,643.00
2,643.00
2,971.00
2,693.00
1,759.00
Gross Profit
2,439.00
2,439.00
3,952.00
2,448.00
1,600.00
Operating Expense
217,134.00
217,134.00
217,034.00
132,630.00
164,622.00
Operating Income
-214,695.00
-214,695.00
-213,082.00
-130,182.00
-163,022.00
Net Non Operating Interest Income Expense
2,390.00
2,390.00
1,980.00
2,631.00
1,472.00
Pretax Income
-212,293.00
-212,293.00
-211,568.00
-127,464.00
-162,314.00
Net Income Common Stockholders
-212,292.00
-212,292.00
-211,577.00
-125,613.00
-159,386.00
Diluted NI Available to Com Stockholders
-212,292.00
-212,292.00
-211,577.00
-125,613.00
-159,386.00
Basic EPS
-2.31
--
-2.37
-1.38
-2.37
Diluted EPS
-2.31
--
-2.37
-1.38
-2.37
Basic Average Shares
91,872.00
--
89,362.00
90,899.20
67,314.83
Diluted Average Shares
91,872.00
--
89,362.00
90,899.20
67,314.83
Total Expenses
219,777.00
219,777.00
220,005.00
135,323.00
166,381.00
Net Income from Continuing & Discontinued Operation
-212,292.00
-212,292.00
-211,577.00
-125,613.00
-159,386.00
Normalized Income
-212,292.00
-212,292.00
-211,577.00
-125,613.00
-159,386.00
Interest Income
2,722.00
2,722.00
2,152.00
2,777.00
1,662.00
Interest Expense
332.00
332.00
172.00
146.00
190.00
Net Interest Income
2,390.00
2,390.00
1,980.00
2,631.00
1,472.00
EBIT
-211,961.00
-211,961.00
-211,396.00
-127,318.00
-162,124.00
EBITDA
-208,646.00
-208,646.00
-207,179.00
-122,981.00
-157,782.00
Reconciled Cost of Revenue
2,643.00
2,643.00
2,971.00
2,693.00
1,759.00
Reconciled Depreciation
3,315.00
3,315.00
4,217.00
4,337.00
4,342.00
Net Income from Continuing Operation Net Minority Interest
-212,292.00
-212,292.00
-211,577.00
-125,613.00
-159,386.00
Normalized EBITDA
-208,646.00
-208,646.00
-207,179.00
-122,981.00
-157,782.00
12/31/2020 - 6/21/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

6610.TWO TWi Biotechnology, Inc.
13.75
+0.73%
 
4194.TWO Holy Stone Healthcare Co., Ltd.
11.40
-0.44%
 
6634.TWO Sinew Pharma Inc.
49.45
-0.40%
 
6549.TWO TaiwanJ Pharmaceuticals Co., Ltd.
7.98
-2.80%
 
6586.TWO CHO Pharma, Inc.
50.90
+1.19%
 
4186.TWO Taiwan Advance Bio-Pharmaceutical Inc.
16.05
+0.94%
 
6564.TWO Enimmune corporation
26.80
-0.56%
 
6945.TWO AP Biosciences Inc
50.80
-3.05%
 
6917.TWO Andros Pharmaceuticals Co.,Ltd
18.20
+0.55%
 
6652.TWO Eusol Biotech Co.,Ltd.
7.77
-0.38%